VG
venBio Global Strategic Fund II L.P.
Other
Browse the complete record of transactions filed by venBio Global Strategic Fund II L.P.. Director active across 1 company, notably Checkmate Pharmaceuticals, Inc.. In total, 7 reports have been logged. Breakdown: 0 buy · 7 sells. Total volume traded: €7m. Activity tracked since 19 April 2022. The latest transaction was filed on 13 May 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to venBio Global Strategic Fund II L.P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
35,850 shares@ US$10.44535.2% of flowCommon StockSEC:0001567619-22-011111:0
18,676 shares@ US$10.38072.6% of flowCommon StockSEC:0001567619-22-010353:0
20,743 shares@ US$10.372.9% of flowCommon StockSEC:0001567619-22-009850:0
153,700 shares@ US$10.383721.8% of flowCommon StockSEC:0001567619-22-009528:0
47,396 shares@ US$10.38026.7% of flowCommon StockSEC:0001567619-22-009203:0
37,430 shares@ US$10.38835.2% of flowCommon StockSEC:0001567619-22-008985:0
399,923 shares@ US$10.415155.5% of flowCommon StockSEC:0001567619-22-008823:0
About venBio Global Strategic Fund II L.P.
venBio Global Strategic Fund II L.P. is a director and insider at Checkmate Pharmaceuticals, Inc.